Reaching the SUMMIT? Benefits and potential risks associated with the use of tirzepatide in heart failure with preserved ejection fraction

被引：0
|
作者：
Hellenkamp, Kristian [1 ,2 ]
Sato, Ryosuke [1 ,2 ]
von Haehling, Stephan [1 ,2 ]
机构：
[1] Univ Gottingen, Med Ctr, Dept Cardiol & Pneumol, Robert-Koch-Str 40, D-37075 Gottingen, Germany
[2] German Ctr Cardiovasc Res DZHK, Partner Site Lower Saxony, Gottingen, Germany
来源：
MED | 2025年 / 6卷 / 02期
关键词：
D O I：
10.1016/j.medj.2024.12.004
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
The SUMMIT trial(1) showed that the dual glucose-dependent insulinotropic polypeptide (GIP) and GLP-1 receptor agonist tirzepatide improves quality of life and reduces worsening heart failure (HF) events in patients with HF with preserved ejection fraction (HFpEF) and obesity. Some concerns, however, remain.
引用
收藏
页码：1 / 4
页数：4
相关论文
共 50 条
  • [1] Tirzepatide for Patients With Heart Failure With Preserved Ejection Fraction and Obesity: the SUMMIT Trial
    Packer, Milton
    CIRCULATION, 2024, 150 (25) : E714 - E714
  • [2] Tirzepatide for Heart Failure with Preserved Ejection Fraction and Obesity
    Packer, Milton
    Zile, Michael R.
    Kramer, Christopher M.
    Baum, Seth J.
    Litwin, Sheldon E.
    Menon, Venu
    Ge, Junbo
    Weerakkody, Govinda J.
    Ou, Yang
    Bunck, Mathijs C.
    Hurt, Karla C.
    Murakami, Masahiro
    Borlaug, Barry A.
    NEW ENGLAND JOURNAL OF MEDICINE, 2024,
  • [3] Toward a New SUMMIT in Heart Failure with Preserved Ejection Fraction
    Felker, G. Michael
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (05):
  • [4] Effects of Tirzepatide on the Clinical and Symptom Burden of Patients with Heart Failure and a Preserved Ejection Fraction, Results from the SUMMIT Trial
    Zile, Michael
    CIRCULATION, 2024, 150 (25) : E746 - E746
  • [5] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    Anker, Stefan D.
    Butler, Javed
    Usman, Muhammad Shariq
    Filippatos, Gerasimos
    Ferreira, Joao Pedro
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans Pieter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure, Eduardo
    Giannetti, Nadia
    Esteban Gomez-Mesa, Juan
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Iwata, Tomoko
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    NATURE MEDICINE, 2022, 28 (12) : 2480 - 2481
  • [6] Effects of Tirzepatide on Cardiorenal End-Organ Damage in Heart Failure and Preserved Ejection Fraction: Insights from the SUMMIT trial
    Borlaug, Barry
    CIRCULATION, 2024, 150 (25) : E737 - E737
  • [7] Empagliflozin benefits in patients with heart failure and preserved ejection fraction
    Nature Medicine, 2022, 28 : 2480 - 2481
  • [8] Effects of Tirzepatide on the Clinical Trajectory of Patients With Heart Failure, Preserved Ejection Fraction, and Obesity
    Zile, Michael R.
    Borlaug, Barry A.
    Kramer, Christopher M.
    Baum, Seth J.
    Litwin, Sheldon E.
    Menon, Venu
    Ou, Yang
    Weerakkody, Govinda J.
    Hurt, Karla C.
    Kanu, Chisom
    Murakami, Masahiro
    Packer, Milton
    SUMMIT Trial Study Grp
    CIRCULATION, 2025, 151 (10) : 656 - 668
  • [9] Competing risks of heart failure with preserved ejection fraction in diabetic patients
    Takeda, Yasuharu
    Sakata, Yasushi
    Mano, Toshiaki
    Ohtani, Tomohito
    Kamimura, Daisuke
    Tamaki, Shunsuke
    Omori, Yosuke
    Tsukamoto, Yasumasa
    Aizawa, Yoshihiro
    Komuro, Issei
    Yamamoto, Kazuhiro
    EUROPEAN JOURNAL OF HEART FAILURE, 2011, 13 (06) : 664 - 669
  • [10] Competing Risks of Heart Failure With Preserved Ejection Fraction in Diabetic Patients
    Takeda, Yasuharu
    Sakata, Yasushi
    Mano, Toshiaki
    Tamaki, Syunsuke
    Omori, Yosuke
    Tsukamoto, Yasumasa
    Aizawa, Yoshihiro
    Yamamoto, Kazuhiro
    Komuro, Issei
    JOURNAL OF CARDIAC FAILURE, 2010, 16 (09) : S171 - S171
12345